Dallas Clinical Trial Explores Slowing Skin Cancer Recurrence With COVID-19 Technology

Dallas and Austin are part of a worldwide clinical trial underway to find a more effective treatment to lower the recurrence of melanoma or high-risk skin cancer. KERA’s Sam Baker talks with Charles Lance Cowey, M.D., medical oncologist at Texas Oncology–Baylor Sammons Cancer Center and an investigator on the studies for the melanoma vaccine.

To read the article and listen to the segment visit KERA.org.